# GORE Flow Reversal System and GORE Embolic Filter Extension Study

Study · id `cardio:ct-nct01343667` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01343667](<https://clinicaltrials.gov/study/NCT01343667>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01343667

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1397 participants.

## Technical summary

Registry record NCT01343667. Non-randomized; no masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2013-11 (actual). Results posted on 2016-02-19.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1397 participants (enrolled count; ClinicalTrials.gov record NCT01343667, source copy `cardio:ctgov-nct01343667-2016-02-19`, retrieved 2026-10-31)
- Start date: 2011-04 (registry gives no type) (ClinicalTrials.gov record NCT01343667, source copy `cardio:ctgov-nct01343667-2016-02-19`, retrieved 2026-10-31)
- Primary completion: 2013-11 (actual) (ClinicalTrials.gov record NCT01343667, source copy `cardio:ctgov-nct01343667-2016-02-19`, retrieved 2026-10-31)
- Completion: 2014-01 (actual) (ClinicalTrials.gov record NCT01343667, source copy `cardio:ctgov-nct01343667-2016-02-19`, retrieved 2026-10-31)
- Results first posted: 2016-02-19 (ClinicalTrials.gov record NCT01343667, source copy `cardio:ctgov-nct01343667-2016-02-19`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT01343667, source copy `cardio:ctgov-nct01343667-2016-02-19`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01343667-2016-02-19`, retrieved 2026-10-31)

## The registry's words

- Brief title: GORE Flow Reversal System and GORE Embolic Filter Extension Study
- Acronym: FREEDOM
- Condition: Carotid Stenosis
- Condition: Constriction, Pathologic
- Condition: Carotid Artery Diseases
- Condition: Cerebrovascular Disorders
- Condition: Brain Diseases
- Condition: Central Nervous System Diseases
- Condition: Nervous System Diseases
- Condition: Arterial Occlusive Diseases
- Condition: Vascular Diseases
- Condition: Cardiovascular Diseases
- Condition: Pathological Conditions, Anatomical
- Intervention (Device): Gore Flow Reversal System
- Intervention (Device): Gore Embolic Filter
- Lead sponsor: W.L.Gore & Associates
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Carotid artery stenosis (`cardio:carotid-stenosis`)
- Registry lists this organization as the lead sponsor: W.L.Gore & Associates (`cardio:org-w-l-gore-associates`)

## Provenance

Content hash: ebc203f19b1fa741ce193a5498dddaef6ec7996faca15dbcadc37e20afabd10f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
